BioStock Investor Pitch: Spermosens
Swedish Spermosens’ vision is to improve diagnostics within the area of male infertility and thus help improve IVF treatments. Using the company’s JUNO-Checked system the sperm’s ability to bond to the egg cell can be tested and the result can help clinicians determine the best treatment course making IVF-treatments more efficient. CEO Ulrik Nilsson visited BioStock’s studio to present the company, its product, and the development plan.See the presentation at biostock.se: https://www.biostock.se/en/2023/01/biostock-investor-pitch-spermosens/ This is a press release from BioStock -